Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jeremia Immanuel Siregar"'
Autor:
Rivaldo Steven Heriyanto, Andree Kurniawan, Felix Wijovi, Devina Adella Halim, Claudia Jodhinata, Elizabeth Marcella, Billy Susanto, Johan Wibowo, Michele Indrawan, Nadia Khoirunnisa Heryadi, Michelle Imanuelly, Jonathan Juniard Anurantha, Timotius Ivan Hariyanto, Chintya Marcellin, Terry Devita Sinaga, Saraswati Anindita Rizki, Novia Sieto, Jeremia Immanuel Siregar, Nata Pratama Hardjo Lugito
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss , Pp 336-338 (2021)
Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals
Externí odkaz:
https://doaj.org/article/2d956e8e294e4a3280b6e0917a7395ac
Publikováno v:
Jurnal Penyakit Dalam Indonesia, Vol 2, Iss 4, Pp 233-239 (2015)
Pendahuluan. Endokarditis infektif (EI) pada pasien hemodialisis (HD) merupakan salah satu contoh EI yang terkait dengan perawatan kesehatan dan menjadi penyebab kematian kedua pada pasien HD setelah penyakit kardiovaskuler. Penggunaan kateter intrav
Externí odkaz:
https://doaj.org/article/fd60e82c052e4c28b6b489290976c537
Autor:
Timotius Ivan Hariyanto, Nata Pratama Hardjo Lugito, Jeremia Immanuel Siregar, Theo Audi Yanto, Andree Kurniawan
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 22:481-489
Background: Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the composite poor outcome of COVID-19. Methods: We systematically se
Autor:
Terry Devita Sinaga, Novia Lauren Sieto, Saraswati Anindita Rizki, B. Susanto, Johan Wibowo, Michele Indrawan, Felix Wijovi, Jonathan Juniard Anurantha, Jeremia Immanuel Siregar, Devina Adella Halim, Michelle Imanuelly, Andree Kurniawan, Claudia Jodhinata, Nadia Khoirunnisa Heryadi, Timotius Ivan Hariyanto, Nata Pratama Hardjo Lugito, E. Marcella, R.S. Heriyanto, Chintya Marcellin
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss, Pp 336-338 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals
Autor:
Vika Damay, Timotius Ivan Hariyanto, Margaret Merlyn Tjiang, Jeremia Immanuel Siregar, Felix Kwenandar, Andree Kurniawan, Nata Pratama Hardjo Lugito, Karunia Valeriani Japar
Publikováno v:
The American Journal of Emergency Medicine
Background Laboratory testing is commonly performed in patients with COVID-19. Each of the laboratory parameters has potential value for risk stratification and prediction of COVID-19 outcomes. This systematic review and meta-analysis aimed to evalua
Autor:
Karunia Valeriani, Margaret Merlyn Tjiang, Jeremia Immanuel Siregar, Timotius Ivan Hariyanto, Andree Kurniawan, Felix Kwenandar, Vika Damay, Nata Pratama Hardjo Lugito
Publikováno v:
The American Journal of Emergency Medicine
Autor:
Andree Kurniawan, Dewi Purnamasari, Jeremia Immanuel Siregar, Ignatius Bima Prasetya, Nata Pratama Hardjo Lugito
Publikováno v:
Abstracts.
Background Gallbladder perforation is a life-threatening event, a severe complication of acute cholecystitis. It is difficult to differentiate to uncomplicated acute cholecystitis. There are three types of gallbladder perforation; (I) acute free perf
Autor:
Nata Pratama Hardjo Lugito, Jeremia Immanuel Siregar, Andree Kurniawan, Ignatius Bima Prasetya
Publikováno v:
Abstracts.
Background Unusual appearance of liver masses poses diagnostic challenges in differentiating between malignancy and abscess. Here, we found an indeterminate case of liver masses from an elderly patient with non-cirrhotic hepatitis C that needs furthe
Autor:
Johan Wibowo, Rivaldo Steven Heriyanto, Felix Wijovi, Devina Adella Halim, Claudia Claudia, Elizabeth Marcella, Billy Susanto, Michele Indrawan, Nadia Khoirunnisa Heryadi, Michelle Imanuelly, Jonathan Juniard Anurantha, Timotius Ivan Hariyanto, Chintya Marcellin, Terry Devita Sinaga, Saraswati Anindita Rizki, Novia Sieto, Jeremia Immanuel Siregar, Nata Pratama Hardjo Lugito, Andree Kurniawan
Publikováno v:
Clinical and Experimental Vaccine Research. 11:89
As coronavirus disease 2019 (COVID-19) continues to spread rapidly causing approximately 186 million confirmed cases around the world, the urgency to reach herd immunity through vaccination is increasing. However, vaccine safety is a top priority to